CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Clinical trial NCT00455897 · TERMINATED
Trial details
- NCT number
- NCT00455897
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.